Magnetic Film Drug Delivery
Magnetic drug delivery is an innovative approach in drug delivery systems where magnetic forces are employed to target and enhance the delivery of therapeutic agents to specific tissues or organs. This technology holds promise for improving the efficiency and precision of drug delivery while minimizing side effects. Here's an overview of key aspects of magnetic drug delivery:
Principles of Magnetic Drug Delivery:
- Magnetic Targeting: Magnetic nanoparticles or carriers loaded with therapeutic agents are guided to the target site by an external magnetic field. This allows for site-specific drug delivery.
- Magnetically Responsive Carriers: Magnetic materials, such as iron oxide nanoparticles, are often incorporated into the drug carrier. These materials respond to an external magnetic field, allowing for controlled movement and localization.
Components of Magnetic Drug Delivery Systems:
- Magnetic Nanoparticles: Typically made of iron oxide, these nanoparticles serve as carriers for therapeutic agents and respond to external magnetic fields.
- Drug Payload: The therapeutic agents, such as drugs or genes, are loaded onto or encapsulated within the magnetic nanoparticles.
- Coating Materials: The magnetic nanoparticles are often coated with biocompatible materials to enhance stability, reduce toxicity, and prevent unwanted interactions with biological components.
Challenges and Future Directions:
- Biocompatibility and Toxicity: Ensuring the biocompatibility of magnetic materials and minimizing potential toxicity are ongoing challenges.
- Optimization of Magnetic Fields: The optimization of magnetic field strength and direction to achieve precise targeting is an area of active research.
- Clinical Translation: Despite promising preclinical results, the clinical translation of magnetic drug delivery systems requires addressing various technical and regulatory challenges.
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, InMedStar and Biona, Russian Federation
Title : Precision diagnostics: Effectiveness of innovative imaging technologies for early detection of lung cancers
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Design and characterization of gum arabic buccal films for protein drug delivery
Krisztian Pamlenyi, University of Szeged, Hungary
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand